Search

everythinglearnresearchcommunity

for

Search:↓

Women over forty can maintain skin and hair health with lifestyle and dietary changes.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

We need better ways to test and understand SARMs to make safer and more effective treatments.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Melatonin treatment helps improve skin health in postmenopausal rats.